Alzheimer's Disease (AD) Animal Model Development Services
To address these critical bottlenecks in the trajectory of therapeutic development for Alzheimer's disease (AD), our AD Animal Model Development Service provides a specialized platform. This service employs advanced generation techniques coupled with rigorous, multi-faceted characterization protocols. Consequently, the aim is to furnish researchers with highly relevant in vivo models. Utilization of such meticulously developed models may facilitate an expedited research process and potentially enhance the predictive power of preclinical efficacy assessments for candidate AD therapeutics.
Introduction of AD Animal Models
AD is an insidiously progressive neurodegenerative disorder characterized by Aβ plaque deposition and tau protein tangle formation in the brain. These pathological changes are closely associated with neural network damage and cognitive decline.
Current research relies heavily on rodent models to explore AD mechanisms and test potential therapies. Although these models can mimic key pathological features, their translational effect is limited. Therefore, a new generation of models is being developed to improve accuracy and drive clinical translation.
Types of Our AD Animal Models
Creative Biolabs offers a comprehensive portfolio of AD animal models, including:
- APP Transgenic Mouse Models
- Amyloid Knock-In Mouse Models
- Tau Transgenic Mouse Models
- Tau Seeding Mouse Model
- Custom-engineered Models
How our AD Animal Model Development Service Can Assist Your Project
Creative Biolabs' AD Animal Model Development Service provides you with cutting-edge solutions to overcome the limitations of traditional AD models and accelerate your drug discovery process. We offer a range of in vitro and in vivo AD models, supported by advanced behavioral, histopathological, and biomarker analyses. Our service is designed to deliver:
- Tailored Solutions: We understand that each research project is unique.
- Accurate Disease Modeling: Our models are carefully selected and characterized to closely mimic the key pathological features of human AD, including amyloid plaques, tau pathology, neuroinflammation, and cognitive decline.
- Comprehensive Characterization: We provide detailed phenotypic characterization of our AD models, including behavioral, cognitive, biochemical, and neuropathological assessments.
- Efficacy Evaluation: We offer a suite of in vivo and in vitro assays to rigorously evaluate the efficacy of your therapeutic interventions.
- Fast Study Timelines: Creative Biolabs maintains proprietary in-house bred mouse model colonies.
Discover How We Can Help - Request a Consultation.
Workflow
Our AD Animal Model Development Service follows a streamlined and efficient workflow:
Case Study
Human TAU Transgenic Mice - TMHT
AD, Parkinsonism linked to chromosome 17 or frontotemporal dementia share the pathogenic process of hyperphosphorylation and aggregation of the microtubule associated protein Tau (MAPT). TMHT (Thy-1 Mutated Human Tau) transgenic mice express the longest human tau isoform tau441 (2N4R) with two mutations, V337M and R406W, under regulatory control of the neuron specific murine Thy-1 promoter.
3xTg Mouse Models
The 3xTg mouse models are viable, fertile, and initially demonstrate no overt physical or behavioral abnormalities. The overexpression of the transgene is restricted to the central nervous system (CNS), including the hippocampus and cerebral cortex. These mice exhibit plaque and tangle pathology.
Why Choose US?
Creative Biolabs is your ideal partner for AD animal model development, offering:
- Extensive Expertise: Creative Biolabs has a team of experienced scientists with deep expertise in AD research and animal model development.
- Cutting-Edge Technology: We utilize state-of-the-art technologies, gene editing and advanced imaging techniques, to generate and characterize highly relevant AD models.
- Customized Solutions: We offer tailored solutions to meet your specific research needs, ensuring that you get the most appropriate model for your studies.
- Comprehensive Services: Creative Biolabs provides a full range of services, from model development to efficacy testing, streamlining your research process.
- Commitment to Quality: We adhere to the highest standards of quality and rigor in our work, ensuring the reliability and reproducibility of our results.
- Accelerated timelines: Creative Biolabs maintains proprietary in-house bred mouse model colonies.
Experience the Creative Biolabs Advantage - Get a Quote Today.
Customer Reviews
"The detailed characterization of the AD mouse models provided by Creative Biolabs significantly improved the translatability of our preclinical findings." [10 Months], Dr. A**n Smith, Neurobiology Research Institute.
"Using Creative Biolabs' custom model generation service, we were able to develop a novel AD model that closely mimics the pathological features of the disease, which greatly facilitated our research on disease mechanisms." [14 Months], Dr. J**e Doe, Pharmaceutical Company.
"Creative Biolabs' expertise in behavioral testing and data analysis was invaluable in evaluating the efficacy of our therapeutic candidate in AD animal models." [9 Months], Prof. M**k Brown, University Medical Center.
Related Services
Creative Biolabs offers a range of complementary services that can support your AD research:
These services are structured to support and potentially expedite critical phases of preclinical research. Institutional expertise integrates sophisticated techniques for model creation, thorough biological characterization across multiple investigative modalities (from molecular profiling to behavioral assessment), and the implementation of rigorous protocols designed for evaluating the efficacy of candidate therapeutic interventions. Further technical specifications regarding these AD model platforms and opportunities for research consultation can be obtained upon direct inquiry.
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Anti-GD2 Antibody (NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- iNeuMab™ Anti-CD20 Antibody (NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-Alpha Synuclein BBB Shuttle Antibody (NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)